Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23.
Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z, Li P, Zhang L, Du Y, Luan H, Li X, Wu L, Li H, Wu H, Li X, Li X, Zhang X, Gong L, Dai L, Sun L, Zuo X, Xu J, Gong H, Li Z, Tong S, Wu M, Li X, Xiao W, Wang G, Zhu P, Shen M, Liu S, Zhao D, Liu W, Wang Y, Huang C, Jiang Q, Liu G, Liu B, Hu S, Zhang W, Zhang Z, You X, Li M, Hao W, Zhao C, Leng X, Bi L, Wang Y, Zhang F, Shi Q, Qi W, Zhang X, Jia Y, Su J, Li Q, Hou Y, Wu Q, Xu D, Zheng W, Zhang M, Wang Q, Fei Y, Zhang X, Li J, Jiang Y, Tian X, Zhao L, Wang L, Zhou B, Li Y, Zhao Y, Zeng X, Ott J, Wang J, Zhang F. Li Y, et al. Among authors: dai l. Nat Genet. 2013 Nov;45(11):1361-5. doi: 10.1038/ng.2779. Epub 2013 Oct 6. Nat Genet. 2013. PMID: 24097066
Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients.
Zhao Y, Li Y, Wang L, Li XF, Huang CB, Wang GC, Zhang XW, Zhang ZL, Zhang X, Xiao WG, Dai L, Wang YF, Hu SX, Li HB, Gong L, Liu B, Sun LY, Zhang MJ, Zhang X, Li YZ, Du DS, Zhang SH, Sun YY, Zhang FC. Zhao Y, et al. Among authors: dai l. Medicine (Baltimore). 2015 Apr;94(16):e667. doi: 10.1097/MD.0000000000000667. Medicine (Baltimore). 2015. PMID: 25906094 Free PMC article.
Association Analysis of the MHC in Lupus Nephritis.
Xu R, Li Q, Liu R, Shen J, Li M, Zhao M, Wang M, Liao Q, Mao H, Li Z, Zhou N, Yin P, Li Y, Tang X, Wu T, Zhong Z, Wang Y, Ai Z, Wang O, Chen N, Yang X, Fang J, Fu P, Gu J, Ye K, Chen J, Dai L, Liu H, Liu Z, Liao Y, Wan J, Ding G, Zhao J, Zhang H, Fu S, Sun L, Zhang X, Yang H, Wang J, Wang J, Liu J, Li Y, Yu X. Xu R, et al. Among authors: dai l. J Am Soc Nephrol. 2017 Nov;28(11):3383-3394. doi: 10.1681/ASN.2016121331. Epub 2017 Jul 28. J Am Soc Nephrol. 2017. PMID: 28754791 Free PMC article.
Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis.
Li Z, Wu X, Leo PJ, De Guzman E, Akkoc N, Breban M, Macfarlane GJ, Mahmoudi M, Marzo-Ortega H, Anderson LK, Wheeler L, Chou CT, Harrison AA, Stebbings S, Jones GT, Bang SY, Wang G, Jamshidi A, Farhadi E, Song J, Lin L, Li M, Wei JC, Martin NG, Wright MJ, Lee M, Wang Y, Zhan J, Zhang JS, Wang X, Jin ZB, Weisman MH, Gensler LS, Ward MM, Rahbar MH, Diekman L, Kim TH, Reveille JD, Wordsworth BP, Xu H, Brown MA; TCRI AS Group. Li Z, et al. Ann Rheum Dis. 2021 Sep;80(9):1168-1174. doi: 10.1136/annrheumdis-2020-219446. Epub 2021 Apr 20. Ann Rheum Dis. 2021. PMID: 34161253 Free PMC article.
Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study.
Mu R, Li C, Li X, Ke Y, Zhao L, Chen L, Wu R, Wu Z, Zuo X, Xie Y, Chen J, Wei W, Liu Y, Li Z, Dai L, Sun L, Liu X, Li Z. Mu R, et al. Among authors: dai l. Lancet Reg Health West Pac. 2021 Mar 22;10:100128. doi: 10.1016/j.lanwpc.2021.100128. eCollection 2021 May. Lancet Reg Health West Pac. 2021. PMID: 34327344 Free PMC article.
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study.
Liu Y, Liu S, Liu L, Gong X, Liu J, Sun L, Liu X, Wu L, Chen L, Wang L, Luo L, Lin J, Tie N, Jiang Z, Wu J, Lu F, Sun H, Li X, Yang N, Chai K, Wei H, Da Z, Zhao C, Dai L, Wang Y, Shi G, Zhang Z, Song H, Guo Q, Liu YC, Li Z. Liu Y, et al. Among authors: dai l. Rheumatol Ther. 2022 Feb;9(1):175-189. doi: 10.1007/s40744-021-00396-8. Epub 2021 Nov 22. Rheumatol Ther. 2022. PMID: 34806155 Free PMC article.
Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trial.
Li J, Xue Z, Wu Z, Bi L, Liu H, Wu L, Liu S, Huang X, Wang Y, Zhang Y, Qi W, He L, Dai L, Sun L, Li X, Shuai Z, Zhao Y, Wang Y, Xu J, Zhang H, Yu H, Chen X, Bao C. Li J, et al. Among authors: dai l. Clin Rheumatol. 2022 Oct;41(10):3005-3016. doi: 10.1007/s10067-022-06199-8. Epub 2022 Jun 8. Clin Rheumatol. 2022. PMID: 35676450 Clinical Trial.
Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.
Zhang X, Yang H, Zuo X, Wu L, Peng J, Li Z, Li H, Ji W, Zhang L, Li X, Dai L, Lu L, Yang N, Wei W, Shuai Z, Jiang Y, Liu Y, Lipsky PE, Chen H; YISTAR study group. Zhang X, et al. Among authors: dai l. Clin Immunol. 2023 Oct;255:109749. doi: 10.1016/j.clim.2023.109749. Epub 2023 Aug 30. Clin Immunol. 2023. PMID: 37657525
6,435 results